The resource has been added to your collection
Onset of Type 2 diabetes occurs when the pancreatic Beta-cell fails to adapt to the increased insulin demand caused by insulin resistance. Morphological and therapeutic intervention studies have uncovered an inflammatory process in islets of patients with Type 2 diabetes characterized by the presence of cytokines, immune cells, ?-cell apoptosis, amyloid deposits, and fibrosis. This insulitis is due to a pathological activation of the innate immune system by metabolic stress and governed by IL-1 signaling. We propose that this insulitis contributes to the decrease in Beta-cell mass and the impaired insulin secretion observed in patients with Type 2 diabetes.
This resource has not yet been reviewed.
Not Rated Yet.